Fertility preservation in gynecologic cancer

Acta Obstetricia et Gynecologica Scandinavica

Volumn 80, Issue 9, 2001, Pages 794-802

  Makar, A P ^a   Trope C ^b  

^a MIDDELHEIM HOSPITAL   (Belgium)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cervical cancer; Conservative therapy; Endometrial cancer; Fertility sparing therapy; Ovarian cancer

Indexed keywords

CLOMIFENE; CONJUGATED ESTROGEN; GONADOTROPIN;

ARTICLE; CANCER INCIDENCE; CANCER INVASION; CANCER RISK; CANCER STAGING; CANCER SURGERY; CLINICAL FEATURE; CONSERVATIVE TREATMENT; ENDOMETRIUM CANCER; FEMALE; FEMALE FERTILITY; FEMALE INFERTILITY; FOLLOW UP; GYNECOLOGIC CANCER; HISTOPATHOLOGY; HUMAN; LAPAROTOMY; OVARY CANCER; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SEXUAL FUNCTION; UTERINE CERVIX CANCER;

ADULT; ENDOMETRIAL NEOPLASMS; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; INFERTILITY, FEMALE; MIDDLE AGED; OVARIAN NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; UTERINE CERVICAL NEOPLASMS;

EID: 0034841310     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2001.080009794.x     Document Type: Article

References (82)

1. Fertility preservation in female oncology patients
2. Follow-up study of 232 patients with 1A1 and 411 patients with stage 1A2 squamous cell carcinoma of the cervix (microinvasive carcinoma)
3. Management of epithelial ovarian tumors of low malignant potential
4. Management of stage I and II ovarian cancer: The value of prognostic factors in therapeutic decisions
5. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumours
6. Descriptive epidemiology of ovarian cancer in Europe
7. Prediction of cancer incidence in the Nordic countries up to the years 2000 and 2010. A collaborative study of the five Nordic cancer registeries
8. Carcinoma of the ovary
9. Chemotherapy for ovarian cancer
10. Prognosis of patients with ovarian cancer and borderline tumours diagnosed in Norway between 1954 and 1993
11. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma
12. Prognostic factors in ovarian cancer
13. Prognostic value of pre- and postoperative serum CA 125 levels in ovarian cancer: New aspects and multivariate analysis
14. Analysis of prognostic factors in stage I epithelial ovarian carcinoma. Importance of degree of differentiation and DNA ploidy in predicting relapse
15. Size of residual disease after debulking surgery is the main prognostic factor in ovarian cancer FIGO stage III
16. DNA ploidy, the most important prognostic factor in patients with borderline tumors of the ovary
17. Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument
18. Prognostic factors in patients with stage I epithelial ovarian cancer
19. Adjuvant treatment for early epithelial ovarian cancer: Results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P)
20. Controversial issues in the management of early epithelial ovarian cancer: Conservative surgery and role of adjuvant therapy
21. Staging laparotomy in early ovarian cancer
22. Prognostic factors for survival in stage I epithelial ovarian carcinoma
23. Pelvic lymphadenectomy in operative treatment of ovarian cancer
24. Lymph node metastasis and retroperitoneal lymphadenectomy in ovarian cancer
25. Pelvic and para-aortic lymphadenectomy in cancer of the ovary
26. Patterns of pelvic and para-aortic lymph node involvement in ovarian cancer
27. Malignant germ cell tumors of the ovary
28. Management of early ovarian cancer: Germ cell and sex cord-stromal tumors
29. Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin and cyclophosphamide
30. Ovarian germ cell malignancies: The Yale University experience
31. Current approaches to diagnosis and treatment of ovarian germ cell malignancies
32. Assessment of the contemporary management of germ cell malignancies of the ovary
33. Survival and reproductive function after treatment of malignant germ cell ovarian tumors
34. Cancer in pregnancy
35. Primary ovarian cancer associated with pregnancy
36. The ovarian carcinoma during pregnancy. A study of 23 cases in Israel between the year 1960 to 1984
37. Cis-platinum combination chemotherapy during pregnancy for advanced epithelial ovarian carcinoma
38. Treatment of advanced epithelial ovarian carcinoma in pregnancy with cisplatin-based chemotherapy
39. Platinum chemotherapy during pregnancy for serous cystadenocarcinoma of the ovary
40. Endodermal sinus tumor of the ovary associated with pregnancy
41. Adjuvant chemotherapy in a pregnant patient with endodermal sinus tumor of the ovary
42. Recurrent endodermal sinus tumor during pregnancy
43. Delivery of a normal infant following cisplatin, vinblastine, and bleomycin (PVB) chemotherapy for malignant teratoma of the ovary during pregnancy
44. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case control studies. I: Methods
45. Treatment of infertility and risk of invasive epithelial ovarian cancer
46. The impact of parity, infertility and the treatment with fertility drugs on the risk of ovarian cancer
47. Cancer in women with fertility
48. 20-Year experience of follow-up of the abnormal smear with colposcopy and histology and treatment by conization or cryosurgery
49. Colposcopic diagnosis and treatment of cervical dysplasia at a single clinic visit
50. Conservative management of cervical intraepithelial neoplasia
51. Epidemiology of adenocarcinoma of the cervix
52. Adenocarcinoma in situ of the cervix: Significance of cone biopsy margins
53. Adenocarcinoma in situ of the uterine cervix. Management and outcome
54. Persistent intraepithelial neoplasia after excision for cervical intraepithelial neoplasia grade III
55. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix
56. Cervical conization as definitive therapy for early invasive squamous carcinoma of the cervix
57. Large loop conization for early invasive cervical cancer
58. Infection and cervical intraepithelial neoplasia
59. Human papillomavirus DNA and genotypes: Prognostic factors for progression of cervical intraepithelial neoplasia
60. Carcinoma of the cervix associated with pregnancy
61. Prospective management of stage IA cervical adenocarcinoma by conization alone to preserve fertility: A preliminary report
62. Gynecologic malignancy and surgery: From quantity to quality of life
63. La Trachélectomie élargie (T.E.), une alternative á l'hysteréctomie radicale dans le traitement des cancers infiltrants développés sur la face externe du col utérin
64. Pregnancies after radical vaginal trachelectomy for early-stage cervical cancer
65. Management of abnormal Papanicolau smears in pregnancy
66. Cervical cancer in pregnancy; reporting on planned delay in therapy
67. Uterine cancer
68. Carcinoma of the uterine cervix in pregnancy. A study of the incidence and treatment in the western region of Sweden 1973 to 1992
69. Epidemiology, etiology, screening, prevention, and diagnosis in female genital cancer
70. Gynecologic malignancy and surgery: From quantity to quality of life
71. Invasive endometrial cancer in uteri resected for atypical endometrial hyperplasia
72. Endometrial hyperplasia and the risk of carcinoma
73. Conservative management of endometrial stromal sarcoma in young women
74. Endometrial carcinoma stage I - Grade II. Conservative treatment followed by healthy twin pregnancy
75. Moderately differentiated endometrial carcinoma cured by conservative treatment
76. A case of grade II adenocarcinoma of the endometrium in pregnancy
77. Endometrial adenocarcinoma associated with intrauterine pregnancy. A report of five cases and a review of the literature
78. Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy?
79. Successful pregnancy in a patient with pseudomyxoma peritonei arising from ovarian mucinous cystadenocarcinoma treated with cisplatin